GR3018165T3 - Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids. - Google Patents

Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids.

Info

Publication number
GR3018165T3
GR3018165T3 GR950403284T GR950403284T GR3018165T3 GR 3018165 T3 GR3018165 T3 GR 3018165T3 GR 950403284 T GR950403284 T GR 950403284T GR 950403284 T GR950403284 T GR 950403284T GR 3018165 T3 GR3018165 T3 GR 3018165T3
Authority
GR
Greece
Prior art keywords
hydroxyacids
indazole
hydroxymethyl
ethers
benzyl
Prior art date
Application number
GR950403284T
Other languages
English (en)
Inventor
Leandro Baiocchi
Bruno Silvestrini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of GR3018165T3 publication Critical patent/GR3018165T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
GR950403284T 1989-02-07 1995-11-22 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids. GR3018165T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
GR3018165T3 true GR3018165T3 (en) 1996-02-29

Family

ID=11261479

Family Applications (2)

Application Number Title Priority Date Filing Date
GR91300073T GR910300073T1 (en) 1989-02-07 1991-11-15 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
GR950403284T GR3018165T3 (en) 1989-02-07 1995-11-22 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR91300073T GR910300073T1 (en) 1989-02-07 1991-11-15 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids

Country Status (36)

Country Link
US (2) US4999367A (el)
EP (1) EP0382276B1 (el)
JP (1) JP2870925B2 (el)
KR (1) KR0145525B1 (el)
CN (2) CN1046505C (el)
AR (1) AR247386A1 (el)
AT (1) ATE127115T1 (el)
AU (1) AU624895B2 (el)
BG (1) BG50273A3 (el)
CA (1) CA2009503C (el)
CZ (1) CZ280121B6 (el)
DD (2) DD295363A5 (el)
DE (2) DE382276T1 (el)
DK (1) DK0382276T3 (el)
EG (1) EG19170A (el)
ES (1) ES2020171T3 (el)
FI (1) FI102678B (el)
GE (1) GEP19971030B (el)
GR (2) GR910300073T1 (el)
HU (1) HU204793B (el)
IL (1) IL93132A (el)
IN (1) IN170957B (el)
IT (1) IT1230441B (el)
LT (1) LT3604B (el)
LV (1) LV10612B (el)
NZ (1) NZ232258A (el)
PE (1) PE25091A1 (el)
PH (1) PH26552A (el)
PL (2) PL163720B1 (el)
PT (1) PT93067B (el)
RO (1) RO106252B1 (el)
RU (3) RU2066318C1 (el)
SK (1) SK278441B6 (el)
UA (1) UA26852C2 (el)
YU (1) YU47943B (el)
ZA (1) ZA90644B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2254870B1 (en) * 2008-03-07 2016-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
US8461194B2 (en) 2008-03-07 2013-06-11 Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
EP2462119B1 (en) * 2009-08-03 2014-06-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required Magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
PT93067A (pt) 1990-08-31
HU204793B (en) 1992-02-28
GR910300073T1 (en) 1991-11-15
ZA90644B (en) 1991-01-30
HU900689D0 (en) 1990-04-28
IN170957B (el) 1992-06-20
EG19170A (en) 1994-11-30
EP0382276A2 (en) 1990-08-16
BG50273A3 (en) 1992-06-15
PL163720B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
ATE127115T1 (de) 1995-09-15
NZ232258A (en) 1991-06-25
YU20690A (sh) 1992-07-20
CA2009503A1 (en) 1990-08-07
UA26852C2 (uk) 1999-12-29
YU47943B (sh) 1996-07-24
PL163730B1 (pl) 1994-04-29
CN1046505C (zh) 1999-11-17
IT1230441B (it) 1991-10-23
CA2009503C (en) 2000-04-11
SK56390A3 (en) 1997-05-07
CN1088201A (zh) 1994-06-22
FI900577A0 (fi) 1990-02-06
PE25091A1 (es) 1991-08-17
AR247386A1 (es) 1994-12-29
JP2870925B2 (ja) 1999-03-17
ES2020171A4 (es) 1991-08-01
HUT53088A (en) 1990-09-28
KR0145525B1 (ko) 1998-08-17
US4999367A (en) 1991-03-12
EP0382276A3 (en) 1990-12-12
IT8947620A0 (it) 1989-02-07
DE382276T1 (de) 1991-11-28
DK0382276T3 (da) 1996-01-15
SK278441B6 (en) 1997-05-07
IL93132A0 (en) 1990-11-05
AU4906690A (en) 1990-08-16
DE69021902D1 (de) 1995-10-05
DD291995A5 (de) 1991-07-18
RU2044729C1 (ru) 1995-09-27
EP0382276B1 (en) 1995-08-30
RO106252B1 (ro) 1993-03-31
LV10612A (lv) 1995-04-20
LT3604B (en) 1995-12-27
CZ280121B6 (cs) 1995-11-15
CN1034016C (zh) 1997-02-12
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
ES2020171T3 (es) 1995-12-01
LTIP872A (en) 1995-03-27
DD295363A5 (de) 1991-10-31
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
KR900012913A (ko) 1990-09-03
PH26552A (en) 1992-08-19
FI102678B (fi) 1999-01-29
AU624895B2 (en) 1992-06-25
LV10612B (en) 1995-08-20
CZ56390A3 (en) 1995-06-14
DE69021902T2 (de) 1996-05-23
US5112986A (en) 1992-05-12
RU2066318C1 (ru) 1996-09-10
IL93132A (en) 1994-05-30
CN1044810A (zh) 1990-08-22

Similar Documents

Publication Publication Date Title
DE69000624D1 (en) Schliessmechanismus.
JPS6445329A (en) Hydroxy ether, manufacture and use
GB2208510B (en) Ethers
DE69000353D1 (en) Fluegelzellenmaschine.
DE69001591D1 (en) Tuerschliesser.
GR3018165T3 (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids.
DE68907587D1 (en) Trappingssystem.
GB8701639D0 (en) Polyglycerol ethers
DE59001953D1 (en) Interferometeranordnung.
DE59008181D1 (en) Trifluormethylcyclohexan-derivate.
DE59001720D1 (en) Spruehvorrichtung.
IL93345A0 (en) Heterocyclic ethers
DE59006531D1 (en) Interferometeranordnung.
DE69002778D1 (en) Pyrolytisches bornitrid.
DE59000988D1 (en) Brueckenuntersichtvorrichtung.
JPS6422856A (en) (azolyl-vinyl)-phenolalkenyl ethers
DE69001652D1 (en) Tuerschliesser.
DE69006476D1 (en) Phenylsubstituierte mesotetraphenylporphyrine.
EP0430866A3 (en) Connection piece
DE69001960D1 (en) Hydroformylierungsverfahren.
HRP940878A2 (en) Ethers 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
DE58904224D1 (en) Thermobimetallmesswerk.
JPS6450869A (en) Hydroxyethylazolyloxime ethers
PH23542A (en) Substituted phenoxybe-(dihalodimethyl-cyclopropylmethyl) ethers
GB8718444D0 (en) Ethers